MRL Ventures Fund Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 59

  • Portfolio
  • 19

  • Exits
  • 19

Exits

MRL Ventures Fund General Information

Company Description

Founded in 2015, MRL Ventures Fund is the corporate venture capital arm of Merck & Co. based in Cambridge, Massachusetts. The firm prefers to invest in seed and early-stage therapeutics companies.

Business Details

Website
www.mrlv.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Corporate Office
  • 320 Bent Street
  • 4th Floor
  • Cambridge, MA 02141
  • United States

MRL Ventures Fund Investments (59)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
VectorY Therapeutics 11-Nov-2026 Later Stage VC Drug Discovery Clinical Trials - Phase 1
InduPro 12-Aug-2026 Drug Discovery Pre-Clinical Trials
Ray Therapeutics 21-Apr-2026 Drug Discovery Clinical Trials - Phase 1
PAQ Therapeutics 22-Jan-2026 Drug Discovery Generating Revenue
Myoventive 01-Jun-2025 Biotechnology Startup
Therini Bio 14-May-2025 Drug Discovery Clinical Trials - Phase 1
Topo Therapeutics 17-Dec-2024 Drug Discovery Startup
Axonis Therapeutics 30-Oct-2024 Drug Discovery Clinical Trials - Phase 1
atbtherapeutics 01-Oct-2024 Later Stage VC Drug Discovery Generating Revenue
Aktis Oncology 20-Sep-2024 Early Stage VC Drug Discovery Generating Revenue
You’re viewing 10 of 59 investments. Get the full list »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MRL Ventures Fund Exits (19)

Company Name Exit Date Exit Type Exit Size
Aktis Oncology 09-Jan-2026 IPO
EyeBio 10-Jul-2024
Caraway Therapeutics 20-Nov-2023
Entrada Therapeutics 02-Nov-2021
Xilio Therapeutics 22-Oct-2021
Invivyd 06-Aug-2021
Imago BioSciences 09-Jul-2021
Tidal Therapeutics 09-Apr-2021
Lava Therapeutics 25-Mar-2021 IPO
Kymera Therapeutics 21-Aug-2020 IPO
You’re viewing 10 of 19 exits. Get the full list »

MRL Ventures Fund Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

MRL Ventures Fund FAQs

  • What is MRL Ventures Fund?

    Founded in 2015, MRL Ventures Fund is the corporate venture capital arm of Merck & Co.

  • When was MRL Ventures Fund founded?

    MRL Ventures Fund was founded in 2015.

  • Where is MRL Ventures Fund headquartered?

    MRL Ventures Fund is headquartered in Cambridge, MA.

  • What is MRL Ventures Fund's total asset value?

    MRL Ventures Fund has around in total assets under management.

  • How many investments has MRL Ventures Fund made?

    MRL Ventures Fund has made 59 investments.

  • What has MRL Ventures Fund invested in?

    MRL Ventures Fund has made numerous investments in companies like VectorY Therapeutics, InduPro, and Ray Therapeutics within the Drug Discovery industry.

  • What has MRL Ventures Fund invested in recently?

    MRL Ventures Fund's latest investment was on 11-Nov-2026 in VectorY Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process